Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18. Juni 2024 16:10 ET
|
Vislink Technologies, Inc.
Mt. Olive, NJ, June 18, 2024 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that effective June 17, 2024, Donald Gilliam was granted a...
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23. Februar 2024 17:10 ET
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
13. Februar 2024 16:05 ET
|
Vislink Technologies, Inc.
Mt. Olive, NJ, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that effective February 12, 2024, Adrian Lambert was granted a...
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
02. Januar 2024 17:23 ET
|
Vislink Technologies, Inc.
Mt. Olive, NJ, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that effective January 1, 2024, Bill Sweeney was granted a...
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07. Juli 2023 16:30 ET
|
Vislink Technologies, Inc.
Mt. Olive, NJ, July 07, 2023 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced today that on July 5, 2023, Steven Teese was granted a time-based...
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12. August 2022 16:05 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Aug. 12, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on its proprietary...
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13. Mai 2022 16:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, May 13, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on its proprietary...
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24. Januar 2020 17:00 ET
|
Vislink Technologies, Inc.
HACKETTSTOWN, NJ, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. announced today that on January 22, 2020 Carleton Miller was granted a time-based and performance-based non-qualified...